How many clinical trials are tracked for neurogenic orthostatic hypotension?

5 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Neurogenic orthostatic hypotension

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for neurogenic orthostatic hypotension

5 trials tracked for neurogenic orthostatic hypotension: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 50 citations.

5Trials tracked

3Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 4 1 Phase 3 2 Phase 2 2

Phase 4 Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study Completed · 50 cited
Phase 3 Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed
Phase 3 Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) Completed
Phase 2 TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) Completed
Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.